These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE. J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926 [Abstract] [Full Text] [Related]
25. Susceptibility of clinical isolates of Candida lusitaniae to five systemic antifungal agents. Favel A, Michel-Nguyen A, Datry A, Challier S, Leclerc F, Chastin C, Fallague K, Regli P. J Antimicrob Chemother; 2004 Mar; 53(3):526-9. PubMed ID: 14963064 [Abstract] [Full Text] [Related]
26. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study. Espinel-Ingroff A, Barchiesi F, Cuenca-Estrella M, Fothergill A, Pfaller MA, Rinaldi M, Rodriguez-Tudela JL, Verweij PE. J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103 [Abstract] [Full Text] [Related]
30. Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions. Pakshir K, Ghasemi N, Zomorodian K, Jowkar F, Nouraei H, Dastgheib L. Acta Dermatovenerol Croat; 2019 Sep; 27(3):137-141. PubMed ID: 31542055 [Abstract] [Full Text] [Related]
31. The distribution of species and susceptibility of amphotericin B and fluconazole of yeast pathogens isolated from sterile sites in Taiwan. Yang YL, Cheng MF, Wang CW, Wang AH, Cheng WT, Lo HJ, Hospitals T. Med Mycol; 2010 Mar; 48(2):328-34. PubMed ID: 20141372 [Abstract] [Full Text] [Related]
32. [Biofilm production and antifungal susceptibility patterns of Candida species]. Yücesoy M, Karaman M. Mikrobiyol Bul; 2004 Mar; 38(1-2):91-8. PubMed ID: 15293907 [Abstract] [Full Text] [Related]
36. [Susceptibility to azoles and amphotericin B of isolates of Candida spp. Experience of a university health network, between 2004 and 2010]. Porte L, León P, Gárate C, Guzmán AM, Labarca J, García P. Rev Chilena Infectol; 2012 Apr; 29(2):149-55. PubMed ID: 22689028 [Abstract] [Full Text] [Related]
38. In vitro activity of antifungal combinations against Candida albicans biofilms. Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E. J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142 [Abstract] [Full Text] [Related]
39. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. Yang YL, Li SY, Cheng HH, Lo HJ, TSARY Hospitals. BMC Infect Dis; 2005 Nov 03; 5():99. PubMed ID: 16266438 [Abstract] [Full Text] [Related]